Agilent Technologies, Inc.· A

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

• 

  Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.

  Assenagon Asset Management S.A. trimmed its stake in Agilent Technologies, Inc. (NYSE: A) by 75.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,454 shares of the medical research company's stock after selling 31,934 shares during the quarter. Assenagon Asset Management S.A.'s

  Aug 15, 2026
• 

  BIP Wealth LLC Makes New $834,000 Investment in Agilent Technologies, Inc. $A

  BIP Wealth LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE: A) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,277 shares of the medical research company's stock, valued at approximately $834,000. Several other institutional investors have also

  Aug 15, 2026
• 

  Comparing Agilent Technologies (NYSE:A) & Many Bright Ideas Technologies (OTCMKTS:MBGNF)

  Agilent Technologies (NYSE: A - Get Free Report) and Many Bright Ideas Technologies (OTCMKTS:MBGNF - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Analyst Recommendations This is a summary

  Aug 8, 2026
• 

  Ashton Thomas Securities LLC Buys 6,387 Shares of Agilent Technologies, Inc. $A

  Ashton Thomas Securities LLC grew its stake in shares of Agilent Technologies, Inc. (NYSE: A) by 47.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,956 shares of the medical research company's stock after acquiring an additional 6,387 shares during

  Jul 30, 2026
• 

  Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

  SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the Eastern Institute of Technology, Ningbo has received an Agilent Research Catalyst (ARC) Award on behalf of Professor Zongwei Cai. The award recognizes Professor Cai's innovative research focused on developing advanced analytical approaches for detecting per- and polyfluoroalkyl substances (PFAS) and other emerging contaminants, a growing area of importance for environmental and public health resea.

  Jul 29, 2026

• EI

  Agilent price target raised to $148 from $144 at Evercore ISI

  Evercore ISI· Vijay Kumar· $148.00
  Jul 6, 2026
• PS

  Agilent initiated with a Neutral at Piper Sandler

  Piper Sandler· David Westenberg· $150.00
  Jun 11, 2026
• HS

  Agilent price target lowered to $165 from $180 at HSBC

  HSBC· Sidharth Sahoo· $165.00
  Jun 3, 2026
• WF

  Agilent (A) PT Lowered to $160 at Wells Fargo

  Wells Fargo· Brandon Couillard· $160.00
  May 28, 2026
• RC

  Agilent initiated with an Outperform at RBC Capital

  RBC Capital· Dan Leonard· $153.00
  May 26, 2026